HONE - HarborOne Bancorp, Inc.
After hours:
Chart Events
Price Crosses Moving Average
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 8.49 |
| Open | 8.49 |
| Bid | 8.26 x 1000 |
| Ask | 8.34 x 1000 |
| Day's Range | 8.27 - 8.50 |
| 52 Week Range | 7.51 - 15.56 |
| Volume | |
| Avg. Volume | 234,732 |
| Market Cap | 395.556M |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | 9.65 |
| EPS (TTM) | 0.86 |
| Earnings Date | Jan 26, 2022 - Jan 31, 2022 |
| Forward Dividend & Yield | 0.30 (3.54%) |
| Ex-Dividend Date | Apr 11, 2023 |
| 1y Target Est | 12.75 |
Fair Value
Related Research
ZacksHere's Why Investors Should Retain STERIS (STE) Stock for Now
Investors are optimistic about STERIS (STE) on strong segmental growth.
- Zacks
STERIS (STE) Continues to Face Dull Dental Sales, Margin Woes
STERIS (STE) competes for pharmaceutical, research and industrial customers against several large companies that have robust product portfolios and global reach.
ZacksSTERIS (STE) Q4 Earnings Beat Estimates, Gross Margin Falls
Heading into fiscal 2024, STERIS (STE) expects many of its fiscal 2023 challenges to abate, including procedure volumes and supply chain constraints.
Motley FoolWhy Shares of Steris Are Up Thursday
Shares of Steris (NYSE: STE) were up 10% Thursday morning, after rising as high as 11.8%. The medical equipment company that sells sterilization products to hospitals and other healthcare companies announced fiscal 2023 fourth-quarter earnings on Wednesday after the markets closed. The company reported fourth-quarter revenue of $1.38 billion, up 14% year over year, and net income of $52.3 million, or $0.52 in earnings per share (EPS), which represent a rise of 258% and 262%, respectively, over the same period last year.
ZacksSteris (STE) Beats Q4 Earnings and Revenue Estimates
Steris (STE) delivered earnings and revenue surprises of 6.98% and 8.71%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Simply Wall St.Investing in STERIS (NYSE:STE) five years ago would have delivered you a 93% gain
STERIS plc ( NYSE:STE ) shareholders might be concerned after seeing the share price drop 14% in the last quarter...
ZacksInari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates
Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 82.61% and 5.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksSteris (STE) Reports Next Week: Wall Street Expects Earnings Growth
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireHarborOne Bancorp, Inc. Announces 2023 First Quarter Earnings
BROCKTON, Mass., April 27, 2023--HarborOne Bancorp, Inc. Announces 2023 First Quarter Earnings
ZacksSTERIS (STE) Set to Post Q4 Earnings: What's in the Cards?
STERIS' (STE) fourth-quarter fiscal 2023 results are likely to reflect an impressive performance across the Healthcare and AST segments, with a gradual improvement in the supply chain.
Business WireHarborOne Bancorp, Inc. Announces 7% Increase in First Quarter 2023 Dividend
BROCKTON, Mass., March 30, 2023--HarborOne Bancorp, Inc. Announces 7% Increase in First Quarter 2023 Dividend
Motley Fool2 Top Dividend Stocks to Buy and Hold for 2023 and Beyond
With that in mind, let's look at two attractive dividend stocks that might not yield enough to make it past your screener search. Steris (NYSE: STE) sells to hospitals and laboratories the sterilization equipment and consumable products, like sanitary wipes, that are needed to maintain a clean and safe working environment. Importantly, of its $4.6 billion in revenue for 2022, management estimates that a whopping 80% of its sales are recurring in nature, as individual hospitals and laboratories tend to buy the same volume of sterilization goods every quarter.
- Simply Wall St.
Don't Buy STERIS plc (NYSE:STE) For Its Next Dividend Without Doing These Checks
It looks like STERIS plc ( NYSE:STE ) is about to go ex-dividend in the next 4 days. The ex-dividend date is one...
Motley FoolWhy Steris Stock Was a Flop This Week
The current earnings season brought some harsh weather to shareholders in Steris (NYSE: STE). The healthcare company unveiled its latest set of quarterly figures on Wednesday and was punished for it, as the stock traded down by almost 12% over the trading week, according to data from S&P Global Market Intelligence. For the third quarter of Steris' fiscal 2023, the company had $1.22 billion in revenue.
ZacksSTERIS (STE) Q3 Earnings Miss Estimates, Margins Down Y/Y
Negative foreign currency and the impact of increased supply chain and inflationary costs hurt STERIS (STE) revenues in the fiscal third quarter.
ZacksSteris (STE) Lags Q3 Earnings and Revenue Estimates
Steris (STE) delivered earnings and revenue surprises of -9.01% and 4.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Business WireHarborOne Bancorp, Inc. Announces 2023 Annual Meeting Information
BROCKTON, Mass., February 03, 2023--HarborOne Bancorp, Inc. Announces 2023 Annual Meeting Information
ZacksHologic (HOLX) Q1 Earnings and Revenues Beat Estimates
Hologic (HOLX) delivered earnings and revenue surprises of 18.89% and 9.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ZacksSTERIS (STE) to Report Q3 Earnings: What's in the Cards?
STERIS' (STE) hospital capital spending is expected to have remained robust in Q3, as evident from the healthcare backlog's recent trend.
- Simply Wall St.
Estimating The Intrinsic Value Of STERIS plc (NYSE:STE)
Today we will run through one way of estimating the intrinsic value of STERIS plc ( NYSE:STE ) by taking the expected...
Motley Fool2 Monster Stocks to Buy Without Any Hesitation
Monster stocks tend to tap into long-lived trends that support growth in their markets, and they typically do so using evergreen business models that don't change much over time. With that in mind, here are two monster growth stocks that are likely to keep performing strongly whether you're investing for three years or for 30 -- and both are ripe for purchase right now. Without Steris, (NYSE: STE), you probably wouldn't find the cleanliness standards of your local hospital to be up to snuff, as it's one of the most crucial suppliers of sterilization products and services for the entire healthcare sector.
Business WireHarborOne Bancorp, Inc. Declares Fourth Quarter Cash Dividend
BROCKTON, Mass., December 21, 2022--HarborOne Bancorp, Inc. Declares Fourth Quarter Cash Dividend
ZacksSTERIS (STE) Gains on New Orders, FX Impact Dents Growth
STERIS (STE) is on track to achieve its stated goal of approximately $50 million of cost synergies in fiscal 2023.
Insider MonkeyHere’s Why STERIS plc (STE) Declined in Q3
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund returned -4.92% net compared to -0.12% return for the Russell 2500 Growth Index. In the quarter, market dynamics worked against the fund’s investment strategy. In […]
